Ibrutinib Induces a Dramatic Improvement for Idiopathic Refractory Ascites Following Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Ibrutinib Induces a Dramatic Improvement for Idiopathic Refractory Ascites Following Allogeneic Hematopoietic Cell Transplantation

Published:2023-09-15 Issue:18 Volume:62 Page:2737-2741
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tazoe Kumiyo¹,Nishimoto Mitsutaka¹,Yamamoto Akira²,Makuuchi Yosuke¹,Kuno Masatomo¹,Okamura Hiroshi¹,Nakashima Yasuhiro¹,Tanaka Sayaka³,Ohsawa Masahiko³,Hino Masayuki¹,Nakamae Hirohisa¹

Affiliation:

1. Hematology, Graduate School of Medicine, Osaka Metropolitan University, Japan

2. Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Japan

3. Department of Diagnostic Pathology, Graduate School of Medicine, Osaka Metropolitan University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/18/62_1139-22/_pdf

Reference13 articles.

1. 1. Leonard JT, Newell LF, Meyers G, et al. Chronic GvHD-associated serositis and pericarditis. Bone Marrow Transplant 50: 1098-1104, 2015.

2. 2. Carreras E, Díaz-Beyá M, Rosiñol L, Martínez C, Fernández-Avilés F, Rovira M. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant 17: 1713-1720, 2011.

3. 3. Bonifazi F, Barbato F, Ravaioli F, et al. Diagnosis and treatment of VOD/SOS after allogeneic hematopoietic stem cell transplantation. Front Immunol 11: 489, 2020.

4. 4. Varma A, Abraham SC, Mehta RS, et al. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Adv 4: 1296-1306, 2020.

5. 5. Dubovsky JA, Beckwith KA, Natarajan G, et al. Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes. Blood 122: 2539-2549, 2013.